(FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 279.93%3.88M | 10,917.25%1.31M | -822.32%-1.08M | 5,282.17%3.83M | -121.88%-177.96K | 364.86%1.02M | -102.37%-12.1K | 127.39%149.1K | 186.19%71.09K | 141.51%813.16K |
Net income from continuing operations | -47.24%-13.11M | -58.11%3.55M | -0.19%-7.54M | 50.77%-2.68M | -45.98%-6.45M | 62.69%-8.91M | 199.19%8.48M | -8.05%-7.52M | -21.21%-5.45M | -14.44%-4.42M |
Operating gains losses | -2,562.75%-3.92M | -178.85%-3.88M | -66.15%587.76K | -250.45%-606.26K | 96.63%-19.85K | -67.11%159.12K | -1,034.83%-1.39M | 24.88%1.74M | 206.16%402.96K | 12.91%-588.72K |
Depreciation and amortization | 14.82%1.17M | 538.03%178.55K | -6.87%311.15K | -6.19%332.98K | -6.13%350.97K | -29.62%1.02M | -111.09%-40.76K | -7.67%334.09K | -0.33%354.95K | 1.87%373.89K |
Asset impairment expenditure | --5.59M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Remuneration paid in stock | 89.24%-20.34K | -38.22%15.78K | 99.89%-10 | 90.03%-7.42K | 78.09%-28.69K | -296.51%-189.08K | -75.71%25.54K | -3,753.57%-9.21K | -246.26%-74.47K | -1,163.09%-130.94K |
Other non cashItems | 16.95%10.28M | 16.83%10.22M | 88.85%17.32K | 34.90%18.4K | 26.20%19.36K | 5,771.08%8.79M | 8,884.40%8.75M | -41.59%9.17K | -21.89%13.64K | -19.84%15.34K |
Change In working capital | 2,541.60%3.89M | 9.27%-14.37M | -1.02%5.54M | 40.36%6.77M | 6.97%5.95M | -99.33%147.4K | -288.18%-15.84M | 20.47%5.6M | 9.31%4.82M | 25.54%5.56M |
-Change in receivables | -340.58%-953.29K | -339.25%-1.71M | -237.34%-733.78K | 109.27%80.78K | 176.27%1.41M | 71.64%-216.37K | 38.18%-388.26K | 374.27%534.28K | -568.62%-871.01K | 167.44%508.62K |
-Change in inventory | -35.08%526.85K | 370.54%941.01K | 288.09%429K | -43.01%134.68K | -262.07%-977.84K | 12.00%811.58K | -14.16%199.99K | -174.52%-228.09K | 165.12%236.32K | 10.02%603.36K |
-Change in prepaid assets | -103.23%-5.44K | 32.76%303.81K | -164.51%-167.77K | 27.58%-159.85K | 118.39%18.36K | 430.25%168.3K | 432.78%228.84K | 32.49%260.07K | -80.93%-220.75K | -76.80%-99.86K |
-Change in payables and accrued expense | 460.10%3.86M | 13.50%-14.36M | 19.29%6.01M | 16.85%6.71M | 15.88%5.5M | -104.94%-1.07M | -292.90%-16.6M | 16.02%5.04M | 14.24%5.74M | 26.72%4.75M |
-Change in other working capital | 1.40%462.95K | -37.50%452.39K | 410.06%7.49K | 104.72%3.07K | ---- | 66.77%456.56K | --723.86K | ---2.42K | ---65.04K | ---199.85K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 279.93%3.88M | 10,917.25%1.31M | -822.32%-1.08M | 5,282.17%3.83M | -121.88%-177.96K | 364.86%1.02M | -102.37%-12.1K | 127.39%149.1K | 186.19%71.09K | 141.51%813.16K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 81.94%-1.85K | 0 | 0 | 0 | 20.03%-1.85K | 91.92%-10.26K | 92.94%-7.37K | 95.59%-606 | 100.56%38 | -11.56%-2.32K |
Net PPE purchase and sale | 81.94%-1.85K | --0 | --0 | --0 | 20.03%-1.85K | 91.92%-10.26K | 92.94%-7.37K | 95.59%-606 | 100.56%38 | -11.56%-2.32K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 81.94%-1.85K | --0 | --0 | --0 | 20.03%-1.85K | 91.92%-10.26K | 92.94%-7.37K | 95.59%-606 | 100.56%38 | -11.56%-2.32K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -13.70%-1.21M | -190.32%-1.57M | -159.97%-185.2K | 1,339.40%429.85K | 125.11%106.27K | -98.08%-1.07M | -170.03%-539.35K | -219.08%-71.24K | 78.45%-34.68K | -77.38%-423.27K |
Net issuance payments of debt | -41.24%-609.73K | -1,543.74%-1.02M | -207.66%-208.31K | 1,569.05%463.25K | 139.32%158.58K | -158.37%-431.69K | 495.68%70.88K | -178.47%-67.71K | 77.03%-31.53K | -310.82%-403.32K |
Cash dividends paid | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | ---- | ---- | -870.11%-33.72K | -201.10%-33.37K | -339.16%-52.26K | ---- | ---- | 69.68%-3.48K | 14.44%-11.08K | 10.98%-11.9K |
Net other financing activities | 4.97%-605.18K | -3.96%-661.93K | 101,583.93%56.83K | -100.39%-31 | 99.42%-47 | -261.48%-636.86K | -2,618.44%-636.69K | 99.63%-56 | 174.18%7.93K | 93.67%-8.05K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -13.70%-1.21M | -190.32%-1.57M | -159.97%-185.2K | 1,339.40%429.85K | 125.11%106.27K | -98.08%-1.07M | -170.03%-539.35K | -219.08%-71.24K | 78.45%-34.68K | -77.38%-423.27K |
Net cash flow | ||||||||||
Beginning cash position | -8.45%203.99K | 62.89%412.5K | 230.33%794.99K | 14.48%657.42K | 2.23%244.67K | -59.92%222.83K | -20.74%253.24K | -38.62%240.67K | -7.21%574.27K | -56.95%239.35K |
Current changes in cash | 4,727.52%2.66M | 54.00%-257.05K | -1,733.84%-1.26M | 11,577.65%4.26M | -118.97%-73.54K | 87.11%-57.55K | -371.66%-558.82K | 115.51%77.25K | 114.57%36.45K | 303.72%387.57K |
Effect of exchange rate changes | -6,508.46%-2.48M | -48.37%271.59K | 1,460.11%879.68K | -1,012.96%-4.12M | 1,023.61%486.28K | -70.23%38.71K | 284.03%526.08K | -115.20%-64.68K | -1,685.31%-370.04K | -59.31%-52.65K |
End cash Position | 89.40%386.36K | 89.40%386.36K | 62.89%412.5K | 230.33%794.99K | 14.48%657.42K | -14.77%203.99K | -14.77%203.99K | -20.74%253.24K | -38.62%240.67K | -7.21%574.27K |
Free cash from | 283.60%3.88M | 6,822.03%1.31M | -825.27%-1.08M | 5,282.17%3.83M | -122.18%-179.81K | 989.43%1.01M | -104.80%-19.47K | 126.61%148.49K | 179.67%71.09K | 142.32%810.84K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.